Case Report
 
A case of pediatric paraparesis secondary to an idiopathic acute transverse myelitis
Joana Teixeira1, Susana Carvalho2, Sofia Martins2, Teresa Pontes2, Álvaro Machado3, Henedina Antunes4
1MD, Pediatric Resident, Pediatrics Department, Hospital de Braga, Portugal.
2MD, Pediatric Consultant, Pediatrics Department, Hospital de Braga, Portugal.
3MD, Neurology Consultant, Neurology Department, Hospital de Braga, Portugal.
4MD, PhD, Pediatric Gastroenterology Senior Consultant and Professor of Pediatrics, Pediatrics Gastrenterology, Hepatology and Nutrition Unit, Hospital de Braga and Life and Health Sciences Research Institute (ICVS), Health Sciences School of University of Minho, Associated Laboratory ICVS/3B 's, Braga / Guimarães, Portugal.

doi:10.5348/ijcri-2014142-CR-10453

Address correspondence to:
Joana Isabel Teixeira
Hospital de Braga, Sete Fontes
4710-243 São Victor, Braga
Portugal
Phone: 00351 91 847 2337
Email: jiteixeira@hotmail.com

Access full text article on other devices

  Access PDF of article on other devices

[HTML Abstract]   [PDF Full Text] [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]


How to cite this article
Teixeira J, Carvalho S, Martins S, Pontes T, Machado Á, Antunes H. A case of pediatric paraparesis secondary to an idiopathic acute transverse myelitis. Int J Case Rep Images 2014;5(12):826–830.


Abstract
Introduction: Acute transverse myelitis (ATM) refers to a frequently idiopathic, segmental spinal cord inflammation. It is a rare condition, in particular in children, and not previously reported in a family retinitis pigmentosa (RP) clinical setting.
Case Report: An 11-year-old previously healthy girl, with a family history of RP, presented with a subacute flaccid paraparesis, with bilateral, up to the fourth dorsal level, mixed sensory hypoesthesia and autonomic dysfunction. Brain and spinal cord magnetic resonance imaging (MRI) showed an extensive, T2-hyperintense, non-contrast enhancing lesion from the second to fifth dorsal levels. Cerebrospinal fluid (CSF) and lab studies were normal, as the ophthalmologic observation. Treated with high-dose corticosteroids and intensive physical therapy, a significant recovery could be seen.
Conclusion: Early pharmacological and physical treatment is fundamental and may indeed change the prognosis of this disease ATM. The family history of RP, although probably incidental, brings nevertheless the issue of a possible etiological contribution, or pathologic common pathways.

Keywords: Transverse myelitis, Retinitis pigmentosa, Paraparesis, Neurogenic urinary bladder


Introduction

Acute transverse myelitis (ATM) refers to a multiple-level segmental spinal cord injury, caused by an acute inflammatory process.

It is very rare, with an estimated incidence of 1–5 cases per million per year [1]. Of these, only 1/5 occur in children, mainly before the age of two (a bimodal incidence can be seen, with a low number of cases between two and five years) [1] [2].

Although commonly idiopathic, an autoimmune disturbance is frequently suspected, and a polyphasic demyelinating disorder can only be disregarded after a reasonable follow-up period.

Clinically, it is characterized by acute to subacute onset of a variable signs of motor, sensory and autonomic dysfunction, which can be localized to a certain level (commonly a series of adjacent levels) of the spinal cord.

It can have major consequences, with residual sensitive, autonomic and motor dysfunction in up to 20% of cases [3].

Retinitis pigmentosa (RP) refers to a heterogeneous group of inherited ocular diseases resulting in a progressive retinal degeneration. It affects 1 in 3,000 –5,000 people and occurs in isolation or in a syndromal manner [4] [5].


Case Report

An 11-year-old previously healthy gymnastics practitioner girl, with anisometropia and family history of RP (mother and maternal aunt), was seen for a 4-day-evolving lower-limb loss of strength and sensitivity, combined with dorsal pain and sphincter dysfunction.

There was no fever or recent relevant traumatic injury.

Neurological examination revealed a left-predominant flaccid paraparesis with normal myotactic and superficial reflexes, a mixed sensory disturbance with algic hypoesthesia up to the fourth dorsal level, and proprioceptive distal loss.

Magnetic resonance imaging (MRI) of the medulla showed slight dorsal high intensity signal in all T2- weighted sequences. Laboratory examination, including all virologies, relevant serologies and immunity screening, were found to be normal. Cerebrospinal fluid (CSF) was also completely normal (including absent oligoclonal bands), as it was the computed tomography (CT) angiography of chest and neck vessels.

Assuming the most likely diagnosis of ATM, she was admitted and started methylprednisolone bolus (30 mg/kg/day).

MRI was repeated at day-12 showing that the signal change extended from the first to fifth dorsal level, was bright in all T2-weighted sequences, did not uptake administered gadolinium, and was more clearly localized in the lateral and anterior columns (Figure 1).

At ophthalmologic evaluation there was no evidence of changes in visual acuity or ocular fundus.

Clinical improvement started at day-5 of methylprednisolone. There was increase muscle strength sufficient for autonomous, although limited, deambulation. It was decided to keep corticosteroid therapy (oral prednisolone 1 mg/kg/day). She also started physiatrist treatment with further muscle strength improvement and gait control. Bladder catheterization was needed because of high post-voiding residual volume.

She was discharged at day-23, with residual paraparesis (Medical Research Council Scale grade 4+), maintaining prednisolone, physiatrist treatment and intermittent bladder catheterization.

Five months later MRI was repeated, showing a reduced dorsal medulla thickness (Figure 2).

Currently, six months after, she maintains paraparesis, being capable of walking for short distances, but needing help for longer distances, personal hygiene and clothing. Neurogenic bladder persists, with secondary nocturnal enuresis, but with spontaneous daytime voiding.


Cursor on image to zoom/Click text to open image
Figure 1: MRI (sagittal section), T2-weighted sequences, showing a first to second dorsal level hyperintense signal, extending to the fourth to fifth dorsal level, more clearly localized in the lateral and anterior columns, with no uptake of administered gadolinium.



Cursor on image to zoom/Click text to open image
Figure 2: MRI (sagittal section), T2-weighted sequences, showing a hyperintense signal of anterior dominance in the middle dorsal region, associated with a reduced dorsal medulla thickness.



Discussion

In ATM, symptoms are grouped on physiological ground as motor, sensory or autonomic. They greatly vary because of the topographical variability (the level, extension and localization) of the disease and, whenever secondary, of the pathology of the underlying cause. As so, clinical onset can be rapidly progressive or more slowly-evolving over a few weeks, and symptoms can affect all limbs, only the lower ones, with or without symmetrical impairment, and predominantly affect one of the three above-mentioned motor, sensory and autonomic systems [2].

MRI is the fundamental study to carry in an emergency setting so to exclude compressive lesions. In ATM, lesions are found mainly in the white matter surrounding the central medullar channel, usually involving several adjacent medullar segments, and are more easily seen in T2-wheighted sequences, where the edema appears bright. This usually precedes the latter medullar atrophy, the sole imagiological evidence of a past ATM [6] [7] [8].

In the majority cases, CSF has increased protein content as well as mild lymphocytosis. However, as spinal cord inflammation may not be evident at the beginning, some authors suggest that lumbar puncture should be repeated between second day and seventh day of the disease [6].

Oligoclonal bands should always be sought, because if they are found in the CSF and not in the blood, they raise the risk for multiple sclerosis [9]. An ophthalmologic evaluation is also recommended for all patients, as an additional finding of optic neuritis has a major implication on the diagnosis (multiple sclerosis or optic neuromyelitis) [6] [9].

Treatment is not consensual. The first line therapy is methylprednisolone for 5–7 days, followed by oral prednisolone (1 mg/kg/day) for 3–4 weeks. Non-pharmacological treatment includes intermittent bladder catheterization and physiotherapy [2] [9].

Etiological considerations in ATM should include viral/bacterial infections, autoimmune and connective tissue diseases, demyelinating diseases (multiple sclerosis, neuromyelitis optica), intra or extra-axial tumors and vascular diseases. Regarding the last etiological group idiopathic spontaneous dorsal spinal cord infarction is another possible unusual etiology of acute paraparesis in children. When it is possible to exclude all of these causes, ATM is then classified as idiopathic [1] [2] [6] .

No etiologic cause of the ATM was found. Given the family history of (RP), a possible association was raised, although both the absence of prior descriptions and of RP signs in our patient, strongly reduce this possibility. There are few descriptions of RP associated with central nervous system infections. It was related to Creutzfeldt-Jakob disease and with congenital toxoplasmosis [4] [10]. There is also been described a close association between Human T-lymphotropic virus type I (HTLV-I) infection associated myelopathy and RP although the pathogenesis remains to be defined [5]. On this ground, we raise the possibility of an etiological contribution, or pathologic common pathways between ATM and RP.


Conclusion

Early pharmacological and physical treatment is fundamental and may indeed change the prognosis of this disease ATM. The family history of RP, although probably incidental, brings nevertheless the issue of a possible etiological contribution, or pathologic common pathways.


References
  1. Oñate Vergara E, Sota Busselo I, García-Santiago J, Gaztañaga Expósito R, Nogués Pérez A, Ruiz Benito MA. Transverse myelitis in immunocompetent children. An Pediatr (Barc) 2004 Aug;61(2):177–80. [Article in Spanish].   [Pubmed]    Back to citation no. 1
  2. Wolf VL, Lupo PJ, Lotze TE. Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis. J Child Neurol 2012 Nov;27(11):1426–36.   [CrossRef]   [Pubmed]    Back to citation no. 2
  3. Thomas T, Branson HM, Verhey LH, et al. The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children. J Child Neurol 2012 Jan;27(1):11–21.   [CrossRef]   [Pubmed]    Back to citation no. 3
  4. Mitrovà E. A case of Creutzfeldt-Jakob disease related to familial retinitis pigmentosa patients. Eur J Epidemiol 1988 Mar;4(1):55–9.   [CrossRef]   [Pubmed]    Back to citation no. 4
  5. Nakao K, Ohba N, Isashiki M, Isashiki Y, Unoki K, Osame M. Pigmentary retinal degeneration in patients with HTLV-I-associated myelopathy. Jpn J Ophthalmol 1989;33(4):383–91.   [Pubmed]    Back to citation no. 5
  6. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002 Aug 27;59(4):499–505.   [Pubmed]    Back to citation no. 6
  7. Alper G, Petropoulou KA, Fitz CR, Kim Y. Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings. Mult Scler 2011 Jan;17(1):74–80.   [CrossRef]   [Pubmed]    Back to citation no. 7
  8. Kim JY, Kim SJ, Bang MS. Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients. Ann Rehabil Med 2012 Jun;36(3):328–3.   [CrossRef]   [Pubmed]    Back to citation no. 8
  9. Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin 2013 Feb;31(1):79–138.   [CrossRef]   [Pubmed]    Back to citation no. 9
  10. Chhabra MS, Prakash G, Vashisht N, Garg SP. Retinitis pigmentosa and congenital toxoplasmosis: A rare coexistence. Indian J Ophthalmol 2007 Jul-Aug;55(4):303–4.   [CrossRef]   [Pubmed]    Back to citation no. 10

[HTML Abstract]   [PDF Full Text]

Author Contributions
Joana Teixeira – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Susana Carvalho – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Sofia Martins – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Teresa Pontes – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Álvaro Machado – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Henedina Antunes – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Guarantor of submission
The corresponding author is the guarantor of submission.
Source of support
None
Conflict of interest
Authors declare no conflict of interest.
Copyright
© 2014 Joana Teixeira et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.



About The Authors

Joana Teixeira is Pediatric Resident at Hospital de Braga.



Susana Carvalho is a Pediatric Consultant at Hospital de Braga.



Sofia Martins is a Pediatric Consultant at Hospital de Braga.



Teresa Pontes is a Pediatric Consultant at Hospital de Braga.



Álvaro Machado is a Neurology Consultant at Hospital de Braga.



Henedina Antunes is a Pediatric Gastroenterology Senior Consultant and Professor of Pediatrics at Hospital de Braga Braga and Life and Health Sciences Research Institute (ICVS), Health Sciences School of University of Minho, Associated Laboratory ICVS/3B 's, Braga, Guimarães.